Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Invested Capital (2017 - 2021)

Historic Invested Capital for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $197.2 million.

  • Cogent Biosciences' Invested Capital rose 98950.12% to $197.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $197.2 million, marking a year-over-year increase of 98950.12%. This contributed to the annual value of $234.7 million for FY2020, which is 63882.94% up from last year.
  • As of Q3 2021, Cogent Biosciences' Invested Capital stood at $197.2 million, which was up 98950.12% from $212.8 million recorded in Q2 2021.
  • Cogent Biosciences' Invested Capital's 5-year high stood at $234.7 million during Q4 2020, with a 5-year trough of -$61.3 million in Q1 2018.
  • In the last 5 years, Cogent Biosciences' Invested Capital had a median value of $44.5 million in 2019 and averaged $71.1 million.
  • Per our database at Business Quant, Cogent Biosciences' Invested Capital crashed by 17746.92% in 2020 and then surged by 100599.24% in 2021.
  • Cogent Biosciences' Invested Capital (Quarter) stood at -$48.8 million in 2017, then skyrocketed by 223.31% to $60.2 million in 2018, then plummeted by 47.27% to $31.8 million in 2019, then skyrocketed by 638.83% to $234.7 million in 2020, then dropped by 15.95% to $197.2 million in 2021.
  • Its last three reported values are $197.2 million in Q3 2021, $212.8 million for Q2 2021, and $226.8 million during Q1 2021.